These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4600899)

  • 21. Treatment of chronic hepatitis.
    Mistilis SP; Lam KC
    Prog Liver Dis; 1972; 4():419-32. PubMed ID: 4569006
    [No Abstract]   [Full Text] [Related]  

  • 22. [Alcoholic liver cirrhosis--the influence of interrupted alcohol consumption and prednisone].
    Juhl E; Tygstrup N
    Nord Med; 1971 Nov; 86(45):1312. PubMed ID: 5117782
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of prednisone on serum cholesterol in patients with cirrhosis of the liver.
    Boberg F; Hattel T; Nielsen OE
    Scand J Gastroenterol; 1972; 7(8):723-6. PubMed ID: 4565595
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

  • 25. The clinical significance of classifications of cirrhosis. A comparison between conventional criteria and numerical taxonomy.
    Winkel P; Juhl E; Tygstrup N
    Scand J Gastroenterol; 1976; 11(1):33-40. PubMed ID: 1251131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of the prognosis of cirrhosis by means of factor analysis of correspondence and descriptive analysis.
    Gauthier A; Zurli J; Cros RC; Sarles H
    Rev Eur Etud Clin Biol; 1972; 17(6):574-81. PubMed ID: 4539651
    [No Abstract]   [Full Text] [Related]  

  • 27. 9- -fluorohydrocortisone induced ascites in alcoholic liver disease.
    Denison EK; Lieberman FL; Reynolds TB
    Gastroenterology; 1971 Oct; 61(4):497-503. PubMed ID: 5114641
    [No Abstract]   [Full Text] [Related]  

  • 28. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables.
    Christensen E; Schlichting P; Andersen PK; Fauerholdt L; Schou G; Pedersen BV; Juhl E; Poulsen H; Tygstrup N
    Scand J Gastroenterol; 1986 Mar; 21(2):163-74. PubMed ID: 3520795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cirrhosis -- sympathomimetics in refractory ascites].
    Z Gastroenterol; 2013 Aug; 51(8):706. PubMed ID: 24298619
    [No Abstract]   [Full Text] [Related]  

  • 30. Prednisone and chronic liver disease. II. Clinical versus morphological criteria for selection of patients for prednisone treatment.
    Schlichting P; Christensen E; Fauerholdt L; Poulsen H; Juhl E; Tygstrup N
    Liver; 1982 Jun; 2(2):113-8. PubMed ID: 7176840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased value does not account for renal sodium retention, a sponteneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis.
    Lieberman FL; Ito S; Reynolds TB
    J Clin Invest; 1969 Jun; 48(6):975-81. PubMed ID: 5771197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A biomedical computer programme system for controlled trials.
    Juhl E; Winkel P; Frank H; Tygstrup N
    Scand J Gastroenterol Suppl; 1970; 7():195-201. PubMed ID: 4917039
    [No Abstract]   [Full Text] [Related]  

  • 33. [Survival in alcoholic cirrhosis after decompensation].
    Prost G; Dechavanne ; Martin C; Evreux M; Tolot F
    Nouv Presse Med; 1972 Dec; 1(45):3031-3. PubMed ID: 4539729
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ascites and alcoholic cirrhosis].
    Gastard J; Cousin P; Boullier G
    Ann Gastroenterol Hepatol (Paris); 1971; 7(2):137-43. PubMed ID: 5573348
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and biological study of seven cases of alcoholic cirrhosis observed three years after cure of ascites].
    LEVRAT M; BRETTE R; RICHARD
    Arch Mal Appar Dig Mal Nutr; 1955 Apr; 44(4):490-5. PubMed ID: 13249682
    [No Abstract]   [Full Text] [Related]  

  • 36. Main causes of death in cirrhosis.
    Schlichting P; Christensen E; Fauerholdt L; Poulsen H; Juhl E; Tygstrup N
    Scand J Gastroenterol; 1983 Oct; 18(7):881-8. PubMed ID: 6374868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesterolone in steatosis and cirrhosis of the liver.
    Figueroa RB
    Acta Hepatogastroenterol (Stuttg); 1973; 20(4):282-90. PubMed ID: 4760412
    [No Abstract]   [Full Text] [Related]  

  • 38. Prednisone in hepatic cirrhosis.
    Robert M; Mach RS
    Lancet; 1969 Mar; 1(7592):469. PubMed ID: 4179530
    [No Abstract]   [Full Text] [Related]  

  • 39. [Intractractable ascites in alcoholic cirrhosis: treatmemt by punctures and reinjections of ascitic fluid associated with diuretics].
    Perrin D; Bredoux P; Arzul C; Bergerault P; Dedieu P; Miniconi P
    Arch Fr Mal App Dig; 1974; 63(5):365-73. PubMed ID: 4463921
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone.
    Christensen E; Fauerholdt L; Schlichting P; Juhl E; Poulsen H; Tygstrup N
    Gastroenterology; 1981 Nov; 81(5):944-52. PubMed ID: 7026343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.